Familial Alzheimer's Disease Of Late Onset: Disease Bioinformatics
Alzheimer's Disease (AD) is a neurological disease that is the most common cause of dementia. Early onset of the disease occurs in patients under the age of 65, which is approximately 5-10% of all diagnosed cases of Alzheimer's. Approximately 13% of this population are patients with Familial Alzheimer’s disease, in which a genetic disposition leads to the disease. There are cases of late onset that occur in Familial Alzheimer’s patients, which is categorized by mutations on different chromosomes. These mutations are currently unknown but are known to differ from the APP and PSEN mutations that lead to Early Onset Familial Alzheimer’s. The disease leads to memory loss, and in the later stages, an inability to perform daily activities. There is currently no cure for Alzheimer’s, but there exist treatments for symptoms as well as a multitude of ongoing research projects.
Familial Alzheimer's Disease Of Late Onset Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Familial Alzheimer's Disease Of Late Onset below!
For more information on how to use Laverne, please read the How to Guide.
We have 146 products for the study of Familial Alzheimer's Disease Of Late Onset that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.